›› 2015, Vol. 43 ›› Issue (2): 113-116.doi: 10.11958/j.issn.0253-9896.2015.02.001

    Next Articles

Effect of intermittent hypoxia on RhoA/ROCK pathway in lung and on the muscularization in pulmonary vascular in rat model

YANG Xiaokun, GAO Mengli, LIU Yameng, LI Caili, CAO Jie△, FENG Jing△   

  • Received:2014-09-30 Revised:2014-10-23 Published:2015-02-15 Online:2015-02-27

Abstract: Abstract:Objective To explore the effect of intermittent hypoxia (IH) on RhoA/ROCK pathway in lung and on the muscularization in pulmonary vascular in rat model. Methods Wistar rats (n=40) were randomly divided into two groups: the normal oxygen control group (n=20) and the IH group ( n=20). For 4 weeks, rats in control group and IH group were ex⁃ posed to intermittent normal oxygen (21% O2) or IH (5%-21% O2) respectively. Then, mRNA transcription and protein trans⁃ lation levels of RhoA/ROCK were examined by Real-time PCR and Western blot. Expression of proliferation cell nuclear an⁃ tigen (PCNA) and α-smooth muscle actin (SM-α-actin ) of lung and pulmonary artery were detected by immunohistochemis⁃ try. Results RhoA mRNA transcription level(0.463±0.067 vs 0.182±0.040), ROCK mRNA transcription level(0.384± 0.062 vs 0.192±0.052), RhoA protein expression level(0.827±0.065 vs 0.424±0.075)and ROCK protein expression level (0.488±0.088 vs 0.336±0.102)were higher in IH group than those in control group(P <0.05);Levels of PCNA in lung tissue ([ 54.67±1.80)% vs (9.14±0.91)%], PCNA in pulmonary artery ([ 49.40±1.21)% vs (8.38±1.13)%], SM-α-actin in lung tis⁃ sue [(42.66±1.63)% vs (35.44±1.41)%] and SM-α-actin in pulmonary artery [(62.62±2.53)% vs (45.54±2.58)%] were also higher in IH group than those in control group(P <0.05). Conclusion Rho/ROCK pathway may play an important role in developing pulmonary hypertension (PH) associated with IH; and IH can promote the muscularization in pulmonary vascular to accelerate PH.

Key words: anoxia, hypertension, pulmonary, proliferating cell nuclear antigen, actins, intermittent hypoxia, pulmonary hypertension, RhoA/ROCK